Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations
Published date:
03/13/2023
Excerpt:
In our multi-institution cohort (N=200), E746_A750del was associated with significantly prolonged progression free survival (PFS) with 1L osimertinib...